A granulocyte reactive monoclonal antibody, 1G10, identifies the Gal beta 1-4 (Fuc alpha 1-3)GlcNAc (X determinant) expressed in HL-60 cells on both glycolipid and glycoprotein molecules

Autor: DL Urdal, TA Brentnall, ID Bernstein, SI Hakomori

Publikováno v: Blood. 62(5)

1G10, a monoclonal IgM antibody that identifies a differentiation antigen on human granulocytes and a subpopulation of monocytes, was found to react specifically with glycosphingolipids bearing the Gal beta 1–4(Fuc alpha 1–3)GlcNAc hapten (X dete

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c53a48b3b9ab6bc56946dcf4ce8c59ed
https://pubmed.ncbi.nlm.nih.gov/6194834

The Pancreatic Cancer Early Detection (PRECEDE) Study is a Global Effort to Drive Early Detection: Baseline Imaging Findings in High-Risk Individuals.

Autor: Zogopoulos G; 1McGill University Health Centre, Montreal, Quebec, Canada., Haimi I; 2New York University Langone Health, New York, NY., Sanoba SA; 2New York University Langone Health, New York, NY., Everett JN; 2New York University Langone Health, New York, NY., Wang Y; 1McGill University Health Centre, Montreal, Quebec, Canada., Katona BW; 3University of Pennsylvania Perelman School of Medicine, Philadelphia, PA., Farrell JJ; 4Yale School of Medicine, Yale University, New Haven, CT., Grossberg AJ; 5Oregon Health & Science University, Portland, OR., Paiella S; 6General and Pancreatic Surgery Unit, Pancreas Institute, University of Verona, Verona, Italy., Klute KA; 7University of Nebraska Medical Center, Omaha, NE., Bi Y; 8Mayo Clinic, Jacksonville, FL., Wallace MB; 8Mayo Clinic, Jacksonville, FL., Kwon RS; 9Michigan Medicine, Ann Arbor, MI., Stoffel EM; 9Michigan Medicine, Ann Arbor, MI., Wadlow RC; 10Inova Schar Cancer Institute, Fairfax, VA., Sussman DA; 11University of Miami Health System, Miami, FL., Merchant NB; 11University of Miami Health System, Miami, FL., Permuth JB; 12Moffitt Cancer Center, Tampa, FL., Golan T; 13Sheba Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Raitses-Gurevich M; 13Sheba Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Lowy AM; 14UC San Diego Health, La Jolla, CA., Liau J; 14UC San Diego Health, La Jolla, CA., Jeter JM; 15Huntsman Cancer Institute, Salt Lake City, UT., Lindberg JM; 16UMass Memorial Health, Worcester, MA., Chung DC; 17Massachusetts General Hospital and Harvard Medical School, Boston, MA., Earl J; 18Ramón y Cajal Health Research Institute, Madrid, Spain., Brentnall TA; 19University of Washington Medical Center, Seattle, WA., Schrader KA; 20BC Cancer, Vancouver, British Columbia, Canada., Kaul V; 21University of Rochester Medical Center, Rochester, NY., Huang C; 2New York University Langone Health, New York, NY., Chandarana H; 2New York University Langone Health, New York, NY., Smerdon C; 22Arbor Research Collaborative for Health, Ann Arbor, MI., Graff JJ; 22Arbor Research Collaborative for Health, Ann Arbor, MI., Kastrinos F; 23Columbia University Irving Medical Center/Herbert Irving Comprehensive Cancer Center, New York, NY., Kupfer SS; 24University of Chicago, Chicago, IL., Lucas AL; 25Icahn School of Medicine at Mount Sinai, New York, NY., Sears RC; 5Oregon Health & Science University, Portland, OR., Brand RE; 26University of Pittsburgh, Pittsburgh, PA., Parmigiani G; 27Dana-Farber Cancer Institute and Harvard T.H. Chan School of Public Health, Boston, MA., Simeone DM; 2New York University Langone Health, New York, NY.

Publikováno v: Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2024 Apr; Vol. 22 (3), pp. 158-166.

Proteomes of Extracellular Vesicles From Pancreatic Cancer Cells and Cancer-Associated Fibroblasts.

Autor: Pan S; From the College of Medicine, Texas A&M University, Bryan, TX., Lai LA; Department of Medicine, University of Washington, Seattle, WA., Simeone DM; Department of Surgery, New York University, School of Medicine, New York, NY., Dawson DW; Department of Pathology and Laboratory Medicine, UCLA, Los Angeles, CA., Yan Y; Department of Surgery, Northwestern University, Evanston, IL., Crnogorac-Jurcevic T; Centre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Chen R; Department of Medicine, Baylor College of Medicine, Houston, TX., Brentnall TA; Department of Medicine, University of Washington, Seattle, WA.

Publikováno v: Pancreas [Pancreas] 2022 Aug 01; Vol. 51 (7), pp. 790-799.

Proteome heterogeneity and malignancy detection in pancreatic cyst fluids.

Autor: Pan S; The Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, Texas, USA.; Department of Integrative Biology and Pharmacology, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas, USA., Brand RE; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Lai LA; Division of Gastroenterology, Department of Medicine, the University of Washington, Seattle, Washington, USA., Dawson DW; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, UCLA, Los Angeles, California, USA.; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, UCLA, Los Angeles, California, USA., Donahue TR; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, UCLA, Los Angeles, California, USA.; Department of Surgery, David Geffen School of Medicine, UCLA, Los Angeles, California, USA., Kim S; Division of Digestive Diseases, David Geffen School of Medicine, UCLA, Los Angeles, California, USA., Khalaf NI; Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA., Othman MO; Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA., Fisher WE; Department of Surgery, Baylor College of Medicine, Houston, Texas, USA., Bronner MP; Department of Pathology, University of Utah, Salt Lake City, Utah, USA., Simeone DM; Department of Surgery, New York University, New York, New York, USA.; Perlmutter Cancer Center, New York University, New York, New York, USA., Brentnall TA; Division of Gastroenterology, Department of Medicine, the University of Washington, Seattle, Washington, USA., Chen R; Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.

Publikováno v: Clinical and translational medicine [Clin Transl Med] 2021 Aug; Vol. 11 (8), pp. e506.

Systemic Proteome Alterations Linked to Early Stage Pancreatic Cancer in Diabetic Patients.

Autor: Peng H; The Brown Foundation Institute of Molecular Medicine, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX 77030, USA., Pan S; The Brown Foundation Institute of Molecular Medicine, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.; Department of Integrative Biology and Pharmacology, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX 77030, USA., Yan Y; Department of Neurosurgery, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX 77030, USA., Brand RE; Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA., Petersen GM; Department of Medicine, Mayo Clinic, Rochester, MN 55902, USA., Chari ST; Department of Medicine, Mayo Clinic, Rochester, MN 55902, USA., Lai LA; Division of Gastroenterology, Department of Medicine, the University of Washington, Seattle, WA 98195, USA., Eng JK; Proteomics Resource, The University of Washington, Seattle, WA 98109, USA., Brentnall TA; Division of Gastroenterology, Department of Medicine, the University of Washington, Seattle, WA 98195, USA., Chen R; Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.

Publikováno v: Cancers [Cancers (Basel)] 2020 Jun 11; Vol. 12 (6). Date of Electronic Publication: 2020 Jun 11.